Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Global DNA hypomethylation and biomarkers for clinical indications in cancer

Global DNA hypomethylation and biomarkers for clinical indications in cancer

US Patent 8728732 · Granted May 20, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds for treati2025
Pharmaceutical agents targeting cancer stem cells2021
Prophylactic protection against viral infections, particularly HIV2020
TGF(β)-MIR200-MIG6 pathway and its use in the treatment of cancer as an indicato2020
Hypermethylation biomarkers associated with poor survival outcomes for head and 2019
Hypermethylation biomarkers associated with poor survival outcomes for head and 2019
Method to use viral and host methylation markers for cervical cancer screening a2019
Method to use viral and host methylation markers for cervical cancer screening a2019
Dual sequence-capture method for quantifying trans renal HPV DNA in urine2017
Hypermethylation biomarkers for detection of head and neck squamous cell cancer2016
Hypermethylation biomarkers for detection of head and neck squamous cell cancer2016
Hypermethylation biomarkers for detection of cervical cancer2014